Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic
Tango Therapeutics, a biotechnology company specializing in cancer treatments, has taken significant measures to address the challenging financial landscape. Recently, the company announced layoffs affecting approximately 20% of its workforce, a strategic move designed to extend its cash runway. As
The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,
A research study published in Nature has revealed a groundbreaking link between the shingles vaccine and a significant reduction in the risk of developing dementia among seniors. By leveraging data from the 2013 implementation of a shingles immunization program in Wales, researchers have identified
Imagine understanding a part of the brain so intricate and vital that it controls many aspects of human life, from hormone regulation to emotional responses. This quest has driven researchers to the hypothalamus, a small yet essential region of the brain that continuously intrigues scientists due
In a groundbreaking study, researchers have uncovered promising evidence suggesting that sulforaphane, a compound found in cruciferous vegetables like broccoli, can play a significant role in preventing lung cancer, particularly among former smokers. As the leading cause of cancer-related deaths,
